Liquid Biopsy Tests Can Identify Patients for Immunotherapy

Two studies in the AACR journal Clinical Cancer Research report that a liquid biopsy test would provide clinicians with a noninvasive way to routinely scan for biomarkers for response to immunotherapy and potentially reach more patients eligible for treatment with these therapeutics.